Your Health, We Care

Home >Drug List>Ivosidenib>Indications of Ivosidenib

Ivosidenib(Tibsovo)

Release date: 2026-01-06 10:48:10     Recommended: 143

It is indicated for patients with susceptible isocitrate dehydrogenase-1 (IDH1) mutations confirmed by a test method approved by the FDA.